SXTC logo

CHINA SXT PHARMACEUTICALS-A

SXTCNASDAQ
🏆 #5258 by market capUS Equity
$502.66▲ $10.10 (+2.01%)
Simulated price
🔔
Track SXTC
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 2.0%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$3M
Small Cap
📈Revenue Growth (YoY)
-34.6%
Declining
📊Gross Margin
21.9%
Moderate
💵FCF Margin
36.9%
Strong
⚖️P/S Ratio
3.0x
Cheap
Otter Score
92
Very Good
No chart data available for SXTC.

Trading Snapshot

Day Range
$494.89 – $509.93
52-Week Range
$1.78 – $83,758.40
Volume
$2.81B
Avg Volume
$1.91B
Shares Outstanding
42.7M
Next Earnings
Dec 2, 2026

Fundamentals Snapshot

Annual Revenue
$1M
Last Q Revenue
$1M
P/E Ratio
—
P/S Ratio
3.0x
EPS (TTM)
$-7.95
Dividend Yield
—
Dilution (1yr)
+0.0%

Why Investors Own SXTC

  • ✓High-growth profile — revenue up +34.0% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 74% gross margin and 16% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

SXTC logo

CHINA SXT PHARMACEUTICALS-A

SXTC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1M▼ −38.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
17.1%▼ −19.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$7M▲ +165.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$4M▲ +71.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
586K▲ +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$27M▲ +$368 YoY
StockOtter · stockotter.space

About CHINA SXT PHARMACEUTICALS-A

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Very Good
92/100

Analyst Price Target

ⓘ
Average Target
$642.46
▲ +27.8% Upside
High Target$767.10
Low Target$590.74
Based on 22 analysts

Latest News & Updates

🚀
Barron’s·2h ago

CHINA SXT PHARMACEUTICALS-A tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
MarketWatch·5h ago

Analysts lift SXTC price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Barron’s·1d ago

CHINA SXT PHARMACEUTICALS-A announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.